human fibrinogen

Ukraine

Drugs containing this active substance

  • FIBRIGA

    The drug is used for the treatment of bleeding and the prevention of bleeding during surgery in patients with congenital fibrinogen deficiency (afibrinogenemia or hypofibrinogenemia). It is also used as adjunctive therapy for uncontrolled severe bleeding in patients with acquired fibrinogen deficiency during surgical interventions.

    Form: powder and solvent for solution for injection/infusion

    Active substance Dosage
    human fibrinogen 1 g

    ATC: B02BB01

    Manufacturer: Octapharma AB (Manufacturer responsible for primary packaging, quality control, batch release)

  • TACHOCOMB

    The drug is used during surgical interventions to improve hemostasis (blood clotting) and tissue sealing. It is also used to secure surgical sutures in vascular surgery and to prevent cerebrospinal fluid leakage following neurosurgical operations.

    Form: adhesive for bonding fabrics

    Active substance Dosage
    human thrombin 2.0 IU/cm2
    human fibrinogen 5.5 mg/cm2

    ATC: B02BC30

    Manufacturer: Takeda Austria GmbH (secondary packaging) / Delpharm Evre (secondary packaging)